BALAXI PHARMACEUTICALS LIMITED (NSE: BALAXI), ISIN INE618N01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BALAXI last traded at ₹24.65 (+2.11%), with a 52-week range of ₹15.20 to ₹52.00 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 65.99%, FIIs 0.00%, DIIs 2.56%, mutual funds 0.00%.
EquiSense Score (ECS): 41/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.